Surgical Science Sweden AB
OTC:SUSRF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Surgical Science Sweden AB
OTC:SUSRF
|
SE |
|
Labrador Gold Corp
XTSX:LAB
|
CA |
|
Adventus Holdings Ltd
SGX:5EF
|
SG |
|
Physiomics PLC
LSE:PYC
|
UK |
|
B
|
Big Cheese Studio SA
WSE:BCS
|
PL |
|
Vitasora Health Ltd
ASX:VHL
|
AU |
|
P
|
Proactis SA
PAR:PROAC
|
FR |
|
A
|
Ananda Development PCL
SET:ANAN
|
TH |
|
C
|
Compagnie de Saint Gobain SA
DUS:GOB
|
FR |
|
D
|
DoorDash Inc
NASDAQ:DASH
|
US |
|
MAP Aktif Adiperkasa Tbk PT
IDX:MAPA
|
ID |
|
Ecopro Co Ltd
KOSDAQ:086520
|
KR |
|
S
|
Search Minerals Inc
OTC:SHCMF
|
CA |
|
Excel Industries Ltd
NSE:EXCELINDUS
|
IN |
|
Sovereign Cloud Holdings Ltd
ASX:SOV
|
AU |
|
C
|
Cimpress PLC
F:3UF
|
IE |
|
US Nuclear Corp
OTC:UCLE
|
US |
|
T
|
Taesung Co Ltd
KOSDAQ:323280
|
KR |
|
C
|
Credit Suisse Group AG
XBER:CSX
|
CH |
|
U
|
Unictron Technologies Corp
TWSE:6792
|
TW |
|
Bank of The Ryukyus Ltd
TSE:8399
|
JP |
|
CVB Financial Corp
NASDAQ:CVBF
|
US |
|
O
|
Ocean Geoloop AS
OSE:OCEAN
|
NO |
|
Robinhood Markets Inc
NASDAQ:HOOD
|
US |
Wall St Price Targets
SUSRF Price Targets Summary
Surgical Science Sweden AB
According to Wall Street analysts, the average 1-year price target for SUSRF is 6.92 USD with a low forecast of 6.05 USD and a high forecast of 9.33 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is SUSRF's stock price target?
Price Target
6.92
USD
According to Wall Street analysts, the average 1-year price target for SUSRF is 6.92 USD with a low forecast of 6.05 USD and a high forecast of 9.33 USD.
What is the Revenue forecast for Surgical Science Sweden AB?
Projected CAGR
10%
Over the last 10 years, the compound annual growth rate for Revenue has been 36%. The projected CAGR for the next 8 years is 10%.
What is the Gross Profit forecast for Surgical Science Sweden AB?
Projected CAGR
12%
Over the last 10 years, the compound annual growth rate for Gross Profit has been 29%. The projected CAGR for the next 5 years is 12%.
What is the Operating Income forecast for Surgical Science Sweden AB?
Projected CAGR
30%
Over the last 10 years, the compound annual growth rate for Operating Income has been 49%. The projected CAGR for the next 5 years is 30%.
What is the Pre-Tax Income forecast for Surgical Science Sweden AB?
Projected CAGR
33%
Over the last 10 years, the compound annual growth rate for Pre-Tax Income has been 51%. The projected CAGR for the next 3 years is 33%.
What is the Net Income forecast for Surgical Science Sweden AB?
Projected CAGR
36%
Over the last 10 years, the compound annual growth rate for Net Income has been 45%. The projected CAGR for the next 5 years is 36%.